Liqiao Han

Title: Innovations of Liqiao Han in Cancer Treatment

Introduction

Liqiao Han is a notable inventor based in Guangdong, China. He has made significant contributions to the field of medicine, particularly in the development of anti-cancer drugs. His innovative work focuses on the preparation and application of new chemical compounds that exhibit promising therapeutic effects.

Latest Patents

Liqiao Han holds a patent for a compound titled "Triptolide acrylate, preparation method therefor and use thereof." This invention introduces a new triptolide derivative, which has been shown to possess anti-cancer activity. The patent details a preparation method for the compound and its medical applications in the formulation of anti-cancer drugs. In animal studies, the triptolide acrylate effectively inhibited tumor growth and demonstrated a significant increase in the protein expression of p53, promoting the apoptosis of tumor cells. Importantly, this compound exhibits lower toxicity to normal cells compared to traditional triptolide.

Career Highlights

Liqiao Han has worked at prominent institutions, including the Guangdong Provincial Hospital of Traditional Chinese Medicine and the Second Affiliated Hospital of Guangzhou University of Chinese Medicine. His experience in these organizations has allowed him to collaborate with leading professionals in the field of medicine and research.

Collaborations

Some of his notable coworkers include Bo Liu and Xianzhang Huang. Their collaborative efforts have contributed to the advancement of research in cancer treatment and the development of innovative therapeutic solutions.

Conclusion

Liqiao Han's contributions to the field of anti-cancer drug development through his innovative patent demonstrate his commitment to improving medical treatments. His work not only highlights the potential of new compounds but also emphasizes the importance of research in combating cancer.